ALKS - Alkermes, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ALKS - Alkermes, Inc.

ALKS 28.49

-0.1%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (178)	9/8/2006 11:56:09 AM
From: tuck	Read Replies (2) of 189

rkrw, I know you have followed this and seen possibilities for Risperdal Consta in particular. There are folks who think their inhaled insulin will be neck and neck with MNKD's, leaving Nektar in the dust. Who knows how Vivitrol will do. The stock has taken a beating recently, and this morning's corporate update at Thomas Weisel isn't helping. I'm wondering how much more downside there is, but one thing that may have gotten ALKS here is doctor and patient acceptance of Risperdal Consta apparently faces a reimbursement hurdle: messages.finance.yahoo.com Thoughts? Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next